Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:atovaquone
|
| gptkbp:ATCCode |
P01AX06
|
| gptkbp:CASNumber |
95233-18-4
|
| gptkbp:chemicalFormula |
C22H19ClO3
|
| gptkbp:FDAApproved |
yes
|
| gptkbp:form |
oral suspension
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mepron
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea headache rash |
| gptkbp:usedFor |
treatment of Pneumocystis jirovecii pneumonia
treatment of toxoplasmosis |
| gptkbp:bfsParent |
gptkb:atovaquone
|
| gptkbp:bfsLayer |
6
|